AR113100A1 - Compuestos que activan la ruta nrf2 - Google Patents
Compuestos que activan la ruta nrf2Info
- Publication number
- AR113100A1 AR113100A1 ARP180102250A ARP180102250A AR113100A1 AR 113100 A1 AR113100 A1 AR 113100A1 AR P180102250 A ARP180102250 A AR P180102250A AR P180102250 A ARP180102250 A AR P180102250A AR 113100 A1 AR113100 A1 AR 113100A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- nrf2
- activate
- route
- peptide compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente se refiere a compuestos peptídicos, cuyos compuestos peptídicos son compuestos de fórmula (1), o una sal, o solvato, o N-óxido, o estereoisómero farmacéuticamente aceptable del mismo, en la que R¹; R²; s; t; u; Aa⁷⁸ y G¹ son como se han definido en el presente documento. Los compuestos peptídicos son útiles para activar la ruta Nrf2 (factor nuclear eritroide 2). Composición farmacéutica, procedimiento, uso.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17382558 | 2017-08-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR113100A1 true AR113100A1 (es) | 2020-01-29 |
Family
ID=59677167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP180102250A AR113100A1 (es) | 2017-08-08 | 2018-08-07 | Compuestos que activan la ruta nrf2 |
Country Status (24)
Country | Link |
---|---|
US (1) | US20200255478A1 (es) |
EP (1) | EP3665182A1 (es) |
JP (1) | JP2020530022A (es) |
KR (1) | KR20200035269A (es) |
CN (1) | CN110997695A (es) |
AR (1) | AR113100A1 (es) |
AU (1) | AU2018314833B2 (es) |
BR (1) | BR112019026306A2 (es) |
CA (1) | CA3066698A1 (es) |
CL (1) | CL2020000305A1 (es) |
CO (1) | CO2020000617A2 (es) |
CR (1) | CR20200056A (es) |
DO (1) | DOP2020000017A (es) |
EA (1) | EA202090432A1 (es) |
EC (1) | ECSP20008530A (es) |
IL (1) | IL272467A (es) |
JO (1) | JOP20200025A1 (es) |
MA (1) | MA49828A (es) |
MX (1) | MX2020001481A (es) |
PE (1) | PE20211460A1 (es) |
PH (1) | PH12019502852A1 (es) |
SG (1) | SG11201913161WA (es) |
TW (1) | TW201919682A (es) |
WO (1) | WO2019030298A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202340226A (zh) * | 2021-12-17 | 2023-10-16 | 德商3B製藥有限公司 | 碳酸酐酶ix配位體 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT7920688V0 (it) | 1979-02-05 | 1979-02-05 | Chiesi Paolo Parma | Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore. |
DE3274065D1 (de) | 1981-07-08 | 1986-12-11 | Draco Ab | Powder inhalator |
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FI69963C (fi) | 1984-10-04 | 1986-09-12 | Orion Yhtymae Oy | Doseringsanordning |
DE3927170A1 (de) | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
IT1237118B (it) | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
DE4027391A1 (de) | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgeraet |
DE69132850T2 (de) | 1990-09-26 | 2002-05-29 | Pharmachemie Bv | Wirbelkammer-Pulverinhalator |
GB9026025D0 (en) | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
DE4239402A1 (de) | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
KR0163472B1 (ko) | 1992-12-18 | 1998-11-16 | 에릭 에스. 딕커 | 분말 약품용 흡입기 |
ATE250439T1 (de) | 1995-04-14 | 2003-10-15 | Smithkline Beecham Corp | Dosierinhalator für salmeterol |
CZ294782B6 (cs) | 1995-06-21 | 2005-03-16 | Sofotec Gmbh & Co. Kg | Inhalátor pro prášková léčiva |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
AU2004235396B2 (en) | 2003-04-29 | 2010-11-25 | Sarepta Therapeutics, Inc. | Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells |
EP1616592B9 (en) | 2004-07-16 | 2011-02-02 | Almirall, S.A. | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge for use with this inhaler |
MX2009009238A (es) | 2007-02-28 | 2009-09-08 | Leo Pharma As | Nuevos inhibidores de fosfodiesterasa. |
WO2009147368A1 (en) | 2008-06-04 | 2009-12-10 | Medical Research Council | Peptides |
JP2012051826A (ja) * | 2010-08-31 | 2012-03-15 | Toray Ind Inc | 環状ペプチド及びその修飾ペプチド並びにKelch様ECH結合タンパク質1の結合阻害物質のスクリーニング方法 |
EP2704749A1 (en) | 2011-05-05 | 2014-03-12 | Sarepta Therapeutics, Inc. | Peptide oligonucleotide conjugates |
IN2014MN00357A (es) | 2011-08-30 | 2015-06-19 | Medical Res Council | |
JP2015067579A (ja) * | 2013-09-30 | 2015-04-13 | 国立大学法人東北大学 | 細胞透過性ペプチド及び当該ペプチドを含む医薬組成物。 |
-
2018
- 2018-08-01 TW TW107126715A patent/TW201919682A/zh unknown
- 2018-08-07 AR ARP180102250A patent/AR113100A1/es unknown
- 2018-08-08 US US16/636,679 patent/US20200255478A1/en not_active Abandoned
- 2018-08-08 JP JP2020506967A patent/JP2020530022A/ja active Pending
- 2018-08-08 SG SG11201913161WA patent/SG11201913161WA/en unknown
- 2018-08-08 CR CR20200056A patent/CR20200056A/es unknown
- 2018-08-08 AU AU2018314833A patent/AU2018314833B2/en not_active Ceased
- 2018-08-08 MA MA049828A patent/MA49828A/fr unknown
- 2018-08-08 KR KR1020207003658A patent/KR20200035269A/ko unknown
- 2018-08-08 JO JOP/2020/0025A patent/JOP20200025A1/ar unknown
- 2018-08-08 EP EP18748945.5A patent/EP3665182A1/en not_active Withdrawn
- 2018-08-08 PE PE2020000172A patent/PE20211460A1/es unknown
- 2018-08-08 CN CN201880051955.6A patent/CN110997695A/zh active Pending
- 2018-08-08 WO PCT/EP2018/071536 patent/WO2019030298A1/en active Application Filing
- 2018-08-08 BR BR112019026306-3A patent/BR112019026306A2/pt not_active Application Discontinuation
- 2018-08-08 EA EA202090432A patent/EA202090432A1/ru unknown
- 2018-08-08 CA CA3066698A patent/CA3066698A1/en not_active Abandoned
- 2018-08-08 MX MX2020001481A patent/MX2020001481A/es unknown
-
2019
- 2019-12-17 PH PH12019502852A patent/PH12019502852A1/en unknown
-
2020
- 2020-01-21 CO CONC2020/0000617A patent/CO2020000617A2/es unknown
- 2020-01-28 DO DO2020000017A patent/DOP2020000017A/es unknown
- 2020-02-04 EC ECSENADI20208530A patent/ECSP20008530A/es unknown
- 2020-02-04 IL IL272467A patent/IL272467A/en unknown
- 2020-02-05 CL CL2020000305A patent/CL2020000305A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20200255478A1 (en) | 2020-08-13 |
KR20200035269A (ko) | 2020-04-02 |
JOP20200025A1 (ar) | 2020-02-04 |
IL272467A (en) | 2020-03-31 |
JP2020530022A (ja) | 2020-10-15 |
PH12019502852A1 (en) | 2020-09-28 |
MX2020001481A (es) | 2020-03-20 |
AU2018314833A1 (en) | 2020-01-02 |
DOP2020000017A (es) | 2020-02-28 |
CR20200056A (es) | 2020-03-16 |
ECSP20008530A (es) | 2020-05-29 |
BR112019026306A2 (pt) | 2020-07-14 |
WO2019030298A1 (en) | 2019-02-14 |
AU2018314833B2 (en) | 2020-03-19 |
CL2020000305A1 (es) | 2020-06-26 |
PE20211460A1 (es) | 2021-08-05 |
MA49828A (fr) | 2020-06-17 |
CA3066698A1 (en) | 2019-02-14 |
EP3665182A1 (en) | 2020-06-17 |
EA202090432A1 (ru) | 2020-06-08 |
CO2020000617A2 (es) | 2020-05-05 |
SG11201913161WA (en) | 2020-01-30 |
CN110997695A (zh) | 2020-04-10 |
TW201919682A (zh) | 2019-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019002777A1 (es) | Compuestos que inhiben la proteína mcl-1. | |
CL2018000730A1 (es) | Compuestos heterocíclicos y usos de los mismos | |
BR112022008375A2 (pt) | Composto cíclico heterocíclico fundido substituído, método de preparação e uso farmacêutico deste | |
CL2017001017A1 (es) | Nuevos compuestos de metil-piperidina útiles para inhibir la sintasa-1 de prostaglandina microsomal e2 | |
CO2017002998A2 (es) | Derivados de tetrahidronaftaleno que inhiben la proteína mcl-1 | |
DOP2020000102A (es) | Compuestos útiles para inhibir a cdk7 | |
CL2016001287A1 (es) | Benzamidas sustituidas y procedimiento para su uso | |
CO2017000222A2 (es) | Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble | |
BR112016028835A2 (pt) | derivados de auristatina e conjugados dos mesmos | |
UY36121A (es) | ?pirazolopiridinas y pirazolopirimidinas?. | |
AR104984A1 (es) | Compuestos selectivos para pyy y sus usos | |
GT201700023A (es) | Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias | |
CL2013002417A1 (es) | Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
CO7111284A2 (es) | Nucleósidos de espirooxetano de uracilo | |
CU24487B1 (es) | Compuestos de tetrahidroquinolinona sustituidos como moduladores de gamma ror | |
PE20181778A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicacion viral del dengue | |
AR094553A1 (es) | Formas de oxadiazolpirazina | |
CL2019001991A1 (es) | Moduladores del receptor de estrógeno. | |
MX2020003732A (es) | Derivado de anillo fusionado como inhibidor del receptor a2a. | |
CU24434B1 (es) | Compuestos derivados de n-(1,5-dimetil-3-oxo-2,3-dihidro-1h-pirazol-4-il)-4-metil-5-isoxazol-3-carboxamida activos como inhibidores selectivos de smurf-1 | |
UY38892A (es) | Moduladores de sting (estimulador de genes de interferón) | |
AR096338A1 (es) | (ciano-dimetil-metil)-isoxazoles y -[1,3,4]tiadiazoles | |
CU20190042A7 (es) | Compuestos derivados de naftiridinona | |
AR113100A1 (es) | Compuestos que activan la ruta nrf2 | |
UY36084A (es) | Activadores de herg policíclicos |